ICD-10-CM Codes
D50-D89
D60-D64
D64-
2023 ICD-10-CM Diagnosis Code D64.81

2023 ICD-10-CM Diagnosis Code D64.81

Anemia due to antineoplastic chemotherapy

2016

2017

2018

2019

2020

2021

2022

2023

Billable/Specific Code

D64.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D64.81 became effective on October 1, 2022.
This is the American ICD-10-CM version of D64.81 - other international versions of ICD-10 D64.81 may differ.

Applicable To

Antineoplastic chemotherapy induced anemia

Type 2 Excludes

Type 2 Excludes Help

A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D64.81) and the excluded code together.

anemia in neoplastic disease (
ICD-10-CM Diagnosis Code D63.0
Anemia in neoplastic disease
Code First
- neoplasm (C00-D49)
Type 1 Excludes
- aplastic anemia due to antineoplastic chemotherapy (D61.1)
Type 2 Excludes
- anemia due to antineoplastic chemotherapy (D64.81)
D63.0
)
aplastic anemia due to antineoplastic chemotherapy (
ICD-10-CM Diagnosis Code D61.1
Drug-induced aplastic anemia
Use Additional
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
D61.1
)

The following code(s) above D64.81 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D64.81:

D50-D89
2023 ICD-10-CM Range D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Type 2 Excludes
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D64
ICD-10-CM Diagnosis Code D64
Other anemias
Type 1 Excludes
- refractory anemia (D46.-)
- refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)
Other anemias

Approximate Synonyms

Anemia due to chemotherapy

ICD-10-CM D64.81 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):

811 Red blood cell disorders with mcc
812 Red blood cell disorders without mcc

Convert D64.81 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change

Code annotations containing back-references to D64.81:

Type 2 Excludes: D63.0

ICD-10-CM Diagnosis Code D63.0
Anemia in neoplastic disease
Code First
- neoplasm (C00-D49)
Type 1 Excludes
- aplastic anemia due to antineoplastic chemotherapy (D61.1)
Type 2 Excludes
- anemia due to antineoplastic chemotherapy (D64.81)

Diagnosis Index entries containing back-references to D64.81:

Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
ICD-10-CM Diagnosis Code D64.9
Anemia, unspecified
- due to (in) (with)
  - antineoplastic chemotherapy D64.81
  - chemotherapy, antineoplastic D64.81

ICD-10-CM Codes Adjacent To D64.81

D63.0 Anemia in neoplastic disease

D63.1 Anemia in chronic kidney disease

D63.8 Anemia in other chronic diseases classified elsewhere

D64 Other anemias

D64.0 Hereditary sideroblastic anemia

D64.1 Secondary sideroblastic anemia due to disease

D64.2 Secondary sideroblastic anemia due to drugs and toxins

D64.3 Other sideroblastic anemias

D64.4 Congenital dyserythropoietic anemia

D64.8 Other specified anemias

D64.81 Anemia due to antineoplastic chemotherapy

D64.89 Other specified anemias

D64.9 Anemia, unspecified

D65 Disseminated intravascular coagulation [defibrination syndrome]

D66 Hereditary factor VIII deficiency

D67 Hereditary factor IX deficiency

D68 Other coagulation defects

D68.0 Von Willebrand disease

D68.00 …… unspecified

D68.01 …… type 1

D68.02 Von Willebrand disease, type 2

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2023 ICD-10-CM Diagnosis Code D64.81

Anemia due to antineoplastic chemotherapy

Anemia in neoplastic disease

Drug-induced aplastic anemia

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Other anemias

Anemia in neoplastic disease

Anemia, unspecified